Skip to main content

Education/ACR/EULAR

Can AI read 20 years of RA X-rays? And how much faster/better than us? 20 years ESPOIR cohort 7500+ joints RADAR algorithm 94–95% accuracy compared with expert readers 99% spe 93% sens #OP0344 #EULAR2026 @RheumNow https://t.co/8hFHCY4SaY
Aurelie Najm @AurelieRheumo( View Tweet )
What is the @Official_ASAS recommended instrument for evaluating peripheral disease activity in axial and peripheral spondyloarthritis? 👉 DAPSA44 ✔️Good construct validity ✔️ High discriminatory capacity From the ASAS-Sparadise study #EULAR2026 @RheumNow https://t.co/Jbdvpn95jE
Nelly ZIADE 🍀 @Nellziade( View Tweet )
Using AI to integrate EHR, SDOH , psychological data - can help finding psychosocial risk factors. Complex cases can be diagnosed using solutions (iceberg health) like this. #EULAR2026 @rheumnow https://t.co/t4keRbpkrx
Bella Mehta @bella_mehta( View Tweet )
Not just ticking boxes! Prof. Rudwaleit on the revised 2025 ASAS/SPARTAN criteria for axSpA What’s new? Providing a stem so criteria will be applied only if w/SpA dx, not just imaging MRI:active inflamm + structural lesions Some SpA features omitted @RheumNow #EULAR2026 https://t.co/NCV0EFvjYa
Can we have an effective, comprehensive score for #SLE #arthritis? #SLEDAI has a problem SJC>2 scores dames as ex #SJC=12 Meet #LAMBDA An attempt to improve a true positive #MSK OUTCOME in #lupus Needs validation esp in pts over time #EULAR2026 @RheumNow #POS1072 @eular_org https://t.co/fr0xuVqFnM
Janet Pope @Janetbirdope( View Tweet )
The axSpA classification has been revised with the 2025 ASAS SPARTAN criteria. 5 abstracts at #EULAR2026 Abstr OP0236, OP0100, OP0239, POS0190 and POS1341. The single most important change in the 2025 criteria: MRI is now the highest-weighted variable and what counts as a https://t.co/xg4R4xRH2D
Antoni Chan MD (Prof) @synovialjoints( View Tweet )
AI use in rheumatology is probably going to be used the first in musculoskeletal imaging. Since patients journey is digitalised. #EULAR2026 @RheumNow We are drowning in healthcare data. https://t.co/61HqtSCQxC
Bella Mehta @bella_mehta( View Tweet )
Digitalization in rheumatology. How can it help? Potential opportunities @RheumNow #EULAR2026 https://t.co/KKImSNLgbq
Bella Mehta @bella_mehta( View Tweet )
Top tips: ⭐️ Summarise the key facts but always provide the source ⭐️ Learn from mistakes to improve what you have ⭐️ Have high quality source material- scan multiple resources for the best quality info and latest news! @RheumNow #EULAR2026

Mrinalini Dey @DrMiniDey( View Tweet )

What makes a good rheum learning platform? @rheumnow’s Dr Jack Cush gives a masterclass in online learning and medical education, including the background to RheumNow. #EULAR2026 @EMEUNET https://t.co/2cXpRXPK13
Mrinalini Dey @DrMiniDey( View Tweet )
What do you think about this cartoon-style format for posters? A- I love it! B- It’s Ok but I prefer classic As for the content: Axia digital therapeutic app improves mobility, BASDAI, sleep an sexual function in 32 patients #POS0199 #EULAR2026 @rheumnow https://t.co/mV83dMF4vi
Nelly ZIADE 🍀 @Nellziade( View Tweet )
Our expanded #EULAR2026 coverage is made possible by support from Bristol Myers Squibb and UCB. All content is independently chosen and produced by the RheumNow faculty.

Dr. John Cush @RheumNow( View Tweet )

Which imaging test has the highest carbon footprint??? Think wisely before prescribing 🩻 #EULAR2026 @RheumNow https://t.co/36Ej8smWRd
Nelly ZIADE 🍀 @Nellziade( View Tweet )
Did you take part in #RheumaVision this year? @cristianasieiro takes us through the past, present & future of this innovative initiative, which held its final yesterday at #EULAR2026. You can watch all the videos online- and be sure to participate next year! @EMEUNET @RheumNow https://t.co/liWzYYbIxI
Mrinalini Dey @DrMiniDey( View Tweet )
🩺🌳When good clinical practice meets reducing environmental burden of healthcare: Rheumatologists can do a lot! Less is more ⬇️ Thank you @eular_org for planning environmental awareness sessions Looking forward to #greener congresses #EULAR2026 @RheumNow https://t.co/5FwARRi92m
Nelly ZIADE 🍀 @Nellziade( View Tweet )
#RheumMadness comes to #EULAR2026! Dr David Leverenz takes us through the background and process of this firm favourite in rheum education. An excellent example of gamification for medical education more broadly. @RheumNow https://t.co/lmgkJbTgBm
Mrinalini Dey @DrMiniDey( View Tweet )
Another reason for NOT prescribing ANA (and other tests) as a “screening” test when not indicated: High carbon footprint! #EULAR2026 @rheumnow https://t.co/BAuzQuZ0Iv
Nelly ZIADE 🍀 @Nellziade( View Tweet )
#EULAR2026 OP0338 More evidence for treatment-to-target in #SLE. Longitudinal renal function analysis of Asia Pacific cohort: achieving LLDAS at least 50% of the time (LLDAS50) is assoc. with reduced eGFR decline independent of age, baseline eGFR, & renal involvement @RheumNow https://t.co/KduU1qtkhF
Md Yuzaiful Md Yusof @Yuz6Yusof( View Tweet )
Looking forward to CAR T cell therapy trials in #SSc Phase 2 and 3 studies presented at #HOT session by Pr Oliver Distler #CAR_T #EULAR2026 @RheumNow https://t.co/bmXZpF2wKg
Nelly ZIADE 🍀 @Nellziade( View Tweet )
Dr. Laura Andreoli shares this slide showing the impact of rheumatic disease in reproductive health as described by Dr. MOstensen. These interplay of factors affect patients and should be taken into consideration when managing fertility & pregnancy. @RheumNow #EULAR2026 https://t.co/fB9kuD4kXo
Starting the “Imaging innovation in RA” session with #OP0343: Singapore investigators developed an AI-based thermography model to detect RA wrist inflammation using thermal hand images, achieving an AUC of 0.87 against ultrasound power doppler as reference. #EULAR2026 @RheumNow https://t.co/2v39E6VOWB
Mrinalini Dey @DrMiniDey( View Tweet )
Personalized #RA treatment based on Ab status and early response: better than routine care? PRIMERA RCT (n=308) says not yet. b/tsDMARD use at 10m: 21% tailored vs 17% routine. Disease activity curves identical. MTX + T2T still the standard for most. @RheumNow #EULAR2026 POS0258 https://t.co/W9FVoqTcMq
Jiha Lee @JihaRheum( View Tweet )

Exploring Idiopathic Myopathies

2026 EULAR Press Release

Idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions with substantial morbidity. EULAR in collaboration with the American College of Rheumatology (ACR) introduced classification criteria for the major subgroups in 2017,1 but there is a need for contemporary

Read Article
RheumNow’s expanded coverage of the #EULAR2026 annual meeting is sponsored by Bristol Myers Squibb and UCB. RheumNow and its faculty independently select all coverage content.

Dr. John Cush @RheumNow( View Tweet )

One of the main changes in the 2025 update on the EULAR guidelines for imaging in SpA is that of MRI replacing CR as the initial imaging modality while CR & low dose CT of SIJs became alternative modalities in the absence of or if with CIs to MRI AbsPOS0682 @RheumNow #EULAR2026 https://t.co/bj2NWKnIGf
×